Roche to receive FDA ruling on food allergy indication soon
During the first quarter of 2024, the US Food and Drug Administration (FDA) will rule on a possible approval of Xolair for the treatment of food allergies, Roche has revealed in a stock exchange notification.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.